Original Research
Accepted on 20 Jan 2026
PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
- 251 views
Original Research
Accepted on 20 Jan 2026
in Cancer Immunity and Immunotherapy
Data Report
Published on 24 Oct 2022
in Gastroenterology and Cancer